CDT Equity CDT
NASDAQ CDT
$2.86 -0.04 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

CDT Equity (CDT) Non-Current Assets (2021 - 2026)

CDT Equity's (CDT) quarterly Non-Current Assets came in at $5000.0 in Q1 2026, up 100.11% YoY from $2498.6 in Q1 2025, and down 99.61% on a QoQ basis from $1.3 million in Q4 2025.

CDT Equity (CDT) Non-Current Assets (2021 - 2026) Analysis & Trends

CDT Equity (CDT) has 6 years of Non-Current Assets data on file, last reported at $5000.0 in Q1 2026.

  • Quarterly Non-Current Assets rose 100.11% year-over-year to $5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5000.0 (down 98.48% YoY) and the FY2025 annual result came in at $1.3 million, down 14.01% from the prior year.
  • Non-Current Assets eased to $5000.0 in Q1 2026, from $1.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $135.7 million in Q3 2022 to a low of -$4.9 million in Q2 2025.
  • A 5-year average of $24.0 million and a median of $1.5 million in 2024 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Non-Current Assets slumped 688.86% — and 2024, when it soared 35120.0%.
  • Tracing CDT's Non-Current Assets over 5 years: stood at -$641639.0 in 2022, then jumped by 332.37% to $1.5 million in 2023, then declined by 0.87% to $1.5 million in 2024, then fell by 14.01% to $1.3 million in 2025, then tumbled by 99.61% to $5000.0 in 2026.
  • The last three Non-Current Assets figures came in at $5000.0 (Q1 2026), $1.3 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.15 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.96 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 938.60 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 468.65 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 18.06 Bn
10 CDT Equity 1.55 Mn 1.55 Mn - 65.04 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 65.04 Mn
Mar 31, 2026 5,000.00
Dec 31, 2025 1.27 Mn
Sep 30, 2025 1.46 Mn
Jun 30, 2025 -4.89 Mn
Mar 31, 2025 -4.45 Mn
Dec 31, 2024 1.48 Mn
Sep 30, 2024 1.60 Mn
Jun 30, 2024 1.70 Mn
Mar 31, 2024 1.76 Mn
Dec 31, 2023 1.49 Mn
Sep 30, 2023 1.58 Mn
Jun 30, 2023 5,000.00
Mar 31, 2023 5,000.00
Dec 31, 2022 -641,639.00
Sep 30, 2022 135.71 Mn
Jun 30, 2022 135.14 Mn
Mar 31, 2022 135.07 Mn
Dec 31, 2021 108,962.00